Connect Biopharma Holdings Limited
CNTB
$2.45
-$0.23-8.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.48M | -49.28M | -44.95M | -17.21M | -15.63M |
| Total Depreciation and Amortization | 704.00K | 681.00K | 678.00K | 669.00K | 660.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.99M | 3.75M | 5.03M | 6.35M | 6.85M |
| Change in Net Operating Assets | 580.00K | 2.57M | 1.37M | -22.79M | -15.49M |
| Cash from Operations | -51.21M | -42.28M | -37.88M | -32.98M | -23.61M |
| Capital Expenditure | -434.00K | -731.00K | -844.00K | -831.00K | -750.00K |
| Sale of Property, Plant, and Equipment | 2.00K | 2.00K | 2.00K | 2.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.25M | -16.20M | -30.58M | -32.51M | -2.70M |
| Cash from Investing | 9.82M | -16.93M | -31.42M | -33.34M | -3.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.09M | 484.00K | 269.00K | 229.00K | 227.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.09M | 484.00K | 269.00K | 229.00K | 227.00K |
| Foreign Exchange rate Adjustments | 408.00K | -626.00K | -177.00K | -299.00K | -595.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.89M | -59.35M | -69.21M | -66.39M | -27.43M |